Atlantic Central Enterprise Ltd.
Limited financial coverage for ALCN.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Operating through its subsidiary, Vista Technologies, Inc. , Atlantic Central Enterprise Ltd. (ACE) provides specialized facilities and services for laser vision correction treatments, including photorefractive keratectomy (PRK), to the medical sector.
- CEO
- Patrick J. Rooney
- IPO
- 2023
- HQ
- Hamilton, HA, BM
Get TickerSpark's AI analysis on ALCN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -9.94
- RSI (14)
- 49
- Avg Volume
- 65.72K
No earnings-call transcripts are available for ALCN yet.
- Free Float
- 0.0%
- Shares Outstanding
- 2.00M
- Float Shares
- 0
Held by 1 ETFs
Biggest fund positions in ALCN by dollar value.
Our ALCN coverage
Recent articles, reports, and earnings notes.
No research on ALCN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALCN report →